|
oculocerebrorenal syndrome
|
DOID_1056 |
|
|
EC 1.8.1.9 (thioredoxin reductase) inhibitor
|
CHEBI_64670 |
|
|
EC 1.8.1.* (oxidoreductase acting on sulfur group of donors, NAD(+) or NADP(+) as acceptor) inhibitor
|
CHEBI_76869 |
|
|
kernicterus
|
DOID_2382 |
|
|
neonatal jaundice
|
DOID_2383 |
|
|
Wernicke encephalopathy
|
DOID_2384 |
|
|
renal artery disease
|
DOID_2388 |
|
|
metal metabolism disorder
|
DOID_896 |
|
|
phospholipid biosynthesis inhibitor
|
CHEBI_83741 |
|
|
leprosy
|
DOID_1024 |
|
|
sodium-dependent Pi-transporter inhibitor
|
CHEBI_63330 |
|
|
EC 3.1.3.1 (alkaline phosphatase) inhibitor
|
CHEBI_63332 |
|
|
hemochromatosis
|
DOID_2352 |
|
|
lung benign neoplasm
|
DOID_3683 |
|
|
respiratory system benign neoplasm
|
DOID_0050621 |
|
|
myelophthisic anemia
|
DOID_2354 |
|
|
MELAS syndrome
|
DOID_3687 |
|
|
mitochondrial encephalomyopathy
|
DOID_890 |
|
|
brachial plexus neuritis
|
DOID_3689 |
|
|
brachial plexus neuropathy
|
DOID_3690 |
|
